NOVEL USE OF TRICYCLIC COMPOUND

Details for Australian Patent Application No. 2001288046 (hide)

Owner SHIONOGI AND CO., LTD.

Inventors HAYASHI, Kunio; ISHIZUKA, Natsuki; SAKAI, Katsunori

Pub. Number AU-A-2001288046

PCT Pub. Number WO2003/024441

Filing date 14 September 2001

Wipo publication date 1 April 2003

International Classifications

A61K 031/15 - Oximes (CNO)

A61K 031/155 - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 031/50 - Pyridazines

A61K 031/505 - Pyrimidines

A61K 031/44 - Non-condensed pyridines

A61K 031/4402 - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 031/4965 - Non-condensed pyrazines

A61K 031/502 - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61K 031/498 - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 031/47 - Quinolines

A61K 031/53 - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 031/426 - 1,3-Thiazoles

A61K 031/4436

A61K 031/4433

A61K 031/4439

A61K 031/357 - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 003/06 Drugs for disorders of the metabolism

A61P 009/10 Drugs for disorders of the cardiovascular system

C07C 259/14 Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups

C07D 237/14 Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 239/26 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 213/16 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 241/12 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 237/30 Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 409/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 241/42 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 215/04 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 213/64 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 239/52 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 237/12 Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 237/16 Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 257/04 Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 277/22 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 409/10 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 405/10 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 401/10 Heterocyclic compounds containing two or more hetero rings

C07D 213/30 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 319/20 Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 295/22 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Event Publications

5 June 2003 Application Open to Public Inspection

  Published as AU-A-2001288046

10 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001288048

2001288045-Novel amide derivatives and medicinal use thereof ugs